Articles by Anna Rose Welch

61. What Pharma Is Learning From Retail: Data, Engagement Go Hand-In-Hand 2/6/2015

    Just as the retail industry grows increasingly customer-centric, the pharma industry is undergoing its own revolution to become patient-centric. While in the retail space, customers have become more willing to share personal information with stores to see more benefits/deals, patients, too, are showing their willingness to voice their needs and dedicate their data to studies in order to see greater medical benefit in the long-run.

62. “Virtual” Recruitment Roundtable: How To Boost Clinical Trial Patient Recruitment 2/3/2015

    As pharma strives to make clinical trials and drug development more patient-centric, current clinical trial recruitment protocols leave much to be desired in terms of boosting patient engagement. Clinical Leader turned to several recruitment experts to get a better picture of what sponsors should consider when recruiting clinical trial participants, especially as patients demand more of a voice in their treatment protocols and clinical trials become increasingly regulated and expensive undertakings.  

63. Obama's Precision Medicine Initiative: The Key To A Patient-Centric Industry? 1/27/2015

    Last week’s State of the Union speech made headlines as Obama announced his Precision Medicine Initiative — a new endeavor to bring personalized medicine to the forefront.

64. New Antibiotic Could Fight Resistance, And Other Recent Pharma News 1/16/2015

    This week in pharma news, a new antibiotic could be the answer to a global health crisis; changes in Indian packaging regulations could lower consumer risk; and a major merger could be good news for the future development of rare disease treatments.

65. “Hyper-Innovation” In Pharma: FDA Approvals Are Just The Start 1/14/2015

    It’s clear, after 2014's surge in FDA approvals, that the industry has increased its productivity. Pharma is slowly clawing its way out of what Forbes has labeled the “painful trough” of 2005-2010. But what do these recent approvals tell us about where we are headed — or where we need to be headed — as an industry?

66. How Bill Gates Is “Drawing” Pharma Into The Future 1/14/2015

    Over the past year, there has been an explosion of debate about the necessity of being vaccinated for illnesses that had been eradicated or have seen lower death rates. I’m not going to enter this argument; rather, I’m more intrigued by a project that has been put forth to celebrate the progress made in global health care with vaccines

67. “Pharmaficial” Intelligence: Could Science Fiction Become A Pharma Reality? 1/14/2015

    All the buzz about wearable technology and the convergence of Google and pharma this past year has made me think about where technology is carrying our industry.

68. How To Develop Patient-Centric Clinical Trials In The Internet Age 1/12/2015

    As technology, people, and data become more closely intertwined in the age of the Internet of Things, the pharma industry is finding its tried and true clinical trial model to be increasingly challenged.

69. Big Pharma “Fountain Of Youth” Drug, FDA Approvals, And Other Pharma News 1/7/2015

    In the news recently, we may be closer to slowing aging with a new “Fountain of Youth” drug; two phase 3 clinical trials have reported developments in schizophrenia and female sexual disorder; and the FDA’s 2014 drug approval record has turned some heads.

70. Will BRICS Have Answers To The HIV Vaccine Search? 1/7/2015

    At the beginning of December, Russia announced it was pushing not just one, but three new HIV vaccines into clinical trials. But Russia is not the only country searching for a successful HIV vaccine as we venture into 2015.